Working alone in a patient’s living room is among the most mentally taxing jobs in medicine. A hospital nurse can lean on a colleague at the next bed or a pharmacist down the hall, while a home-visit nurse usually has only a phone and her own judgment to fall back on.
Whether a tightly constrained AI chatbot can ease that strain was the question behind a randomized controlled trial from Japan, published in BMC Nursing. The work was led by Takemasa Ishikawa, of the Nana-r Home-visit Nursing Development Center at Tekix Corporation and Osaka Metropolitan University, alongside colleagues from Shizuoka University, Nara Medical University and Hiroshima University.
For the intervention, the researchers turned to NotebookLM, which can be tied down to a fixed set of documents. They loaded it with vetted clinical guidelines, so the answers it produced came from evidence rather than improvisation.
The web-based trial ran in March 2026 and split 140 practicing home-visit nurses evenly into two groups. Every nurse faced the same made-up visit: an older adult who lives alone with chronic heart failure, a case that calls for weighing fluid status, how faithfully medications are taken, the person’s ability to care for themselves, and any warning signs of a decline. One set of nurses was free to ask the guideline-anchored system questions throughout the case, while the other worked with no outside help at all. The researchers then measured perceived mental effort and confidence in the conclusions each nurse reached.
Beyond its result, the design is instructive. Tying a model to trusted documents sidesteps the hallucination risk that keeps clinicians wary of open-ended chatbots, while still giving an isolated nurse something to consult. For a workforce stretched thin by home care demand, that combination may be the practical middle path.
